During the past decade, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 28 clinical trials were completed, i.e. on average, 93.3% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 9 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center" #1 sponsor was "Children's Oncology Group" with 21 trials, followed by "Alliance for Clinical Trials in Oncology" with 17 trials sponsored, "Pfizer" with 12 trials sponsored, "Seagen Inc." with 5 trials sponsored and "Radiation Therapy Oncology Group" with 5 trials sponsored. Other sponsors include 53 different institutions and companies that sponsored additional 50 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 55 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "Merck Sharp & Dohme LLC" with 3 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center" are "Lung Cancer" (13 trials), "Leukemia" (9 trials), "Prostate Cancer" (8 trials), "Breast Cancer" (7 trials) and "Lymphoma" (7 trials). Many other conditions were trialed in "Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center" in a lesser frequency.

Most popular intervention types in "Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center" are "Drug" (97 trials), "Biological" (23 trials), "Radiation" (19 trials), "Procedure" (14 trials) and "Other" (11 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (16 trials), "radiation therapy" (14 trials), "carboplatin" (12 trials), "etoposide" (11 trials) and "filgrastim" (11 trials). Other intervention names were less common.

The vast majority of trials in "Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center" are 97 trials for "All" genders, 12 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center". 1 are not yet recruiting, 10 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 75 completed trials in Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, 25 "Phase 1" clinical trials were conducted, 52 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".